Your browser doesn't support javascript.
loading
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial.
Xu, Jianming; Jiang, Haiping; Pan, Yueyin; Gu, Kangsheng; Cang, Shundong; Han, Lei; Shu, Yongqian; Li, Jiayi; Zhao, Junhui; Pan, Hongming; Luo, Suxia; Qin, Yanru; Guo, Qunyi; Bai, Yuxian; Ling, Yang; Yang, Jianwei; Yan, Zhilong; Yang, Lei; Tang, Yong; He, Yifu; Zhang, Liangming; Liang, Xinjun; Niu, Zuoxing; Zhang, Jingdong; Mao, Yong; Guo, Yingmei; Peng, Bo; Li, Ziran; Liu, Ying; Wang, Yan; Zhou, Hui.
Affiliation
  • Xu J; The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Jiang H; The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
  • Pan Y; Anhui Provincial Hospital, Hefei, China.
  • Gu K; The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Cang S; Henan Provincial People's Hospital, Zhengzhou, China.
  • Han L; Affiliated Hospital of Jining Medical University, Jining, China.
  • Shu Y; Jiangsu Provincial Hospital, Nanjing, China.
  • Li J; The First Affiliated Hospital of Xiamen University, Xiamen, China.
  • Zhao J; Qinghai University Affiliated Hospital, Xining, China.
  • Pan H; Sir Run Run Shaw Hospital School of Medicine, Zhejiang University, Hangzhou, China.
  • Luo S; Henan Cancer Hospital, Zhengzhou, China.
  • Qin Y; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Guo Q; Taizhou Hospital of Zhejiang Province, Linhai, China.
  • Bai Y; Harbin Medical University Cancer Hospital, Harbin, China.
  • Ling Y; Changzhou Tumor Hospital, Changzhou, China.
  • Yang J; Fujian Provincial Cancer Hospital, Fuzhou, China.
  • Yan Z; Ningbo First Hospital, Ningbo, China.
  • Yang L; Nantong Tumor Hospital, Nantong, China.
  • Tang Y; The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China.
  • He Y; Anhui Provincial Cancer Hospital, Hefei, China.
  • Zhang L; Yantai Yuhuangding Hospital, Yantai, China.
  • Liang X; Hubei Cancer Hospital, Wuhan, China.
  • Niu Z; Affiliated Cancer Hospital of Shandong First Medical University, Jinan, China.
  • Zhang J; Liaoning Cancer Hospital, Shenyang, China.
  • Mao Y; Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Guo Y; Innovent Biologics, Inc., Suzhou, China.
  • Peng B; Innovent Biologics, Inc., Suzhou, China.
  • Li Z; Innovent Biologics, Inc., Suzhou, China.
  • Liu Y; Innovent Biologics, Inc., Suzhou, China.
  • Wang Y; Innovent Biologics, Inc., Suzhou, China.
  • Zhou H; Innovent Biologics, Inc., Suzhou, China.
JAMA ; 330(21): 2064-2074, 2023 12 05.
Article in En | MEDLINE | ID: mdl-38051328
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Esophagogastric Junction / Antibodies, Monoclonal, Humanized Language: En Journal: JAMA Year: 2023 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Esophagogastric Junction / Antibodies, Monoclonal, Humanized Language: En Journal: JAMA Year: 2023 Type: Article Affiliation country: China